Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
-47.4%/yr
Quarterly compound
Percentile
P62
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.99% |
| Q3 2025 | -3.47% |
| Q2 2025 | 8.78% |
| Q1 2025 | -6.98% |
| Q4 2024 | -1.27% |
| Q3 2024 | 0.85% |
| Q2 2024 | 4.60% |
| Q1 2024 | 2.85% |
| Q4 2023 | 2.45% |
| Q3 2023 | 4.58% |
| Q2 2023 | 1.27% |
| Q1 2023 | 1.91% |
| Q4 2022 | 13.68% |
| Q3 2022 | -12.77% |
| Q2 2022 | 8.73% |
| Q1 2022 | 2.55% |
| Q4 2021 | -3.89% |
| Q3 2021 | -11.67% |
| Q2 2021 | 9.42% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 55.79% |
| Q2 2020 | -43.17% |
| Q1 2020 | -15.94% |
| Q4 2019 | 4.72% |
| Q3 2019 | -13.51% |
| Q2 2019 | -0.55% |
| Q1 2019 | -0.09% |
| Q4 2018 | 7.17% |
| Q3 2018 | 0.70% |
| Q2 2018 | 3.82% |
| Q1 2018 | -0.26% |
| Q4 2017 | 2.00% |
| Q3 2017 | -5.14% |
| Q2 2017 | 1.83% |
| Q1 2017 | 0.20% |
| Q4 2016 | 10.70% |
| Q3 2016 | -4.83% |
| Q2 2016 | -2.10% |
| Q1 2016 | -1.45% |